Shell Companies
Compare Stocks
5 / 10Stock Comparison
ATII vs ACIC vs HCI vs UPC vs HRTG
Revenue, margins, valuation, and 5-year total return — side by side.
Insurance - Property & Casualty
Insurance - Property & Casualty
Drug Manufacturers - Specialty & Generic
Insurance - Property & Casualty
ATII vs ACIC vs HCI vs UPC vs HRTG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Shell Companies | Insurance - Property & Casualty | Insurance - Property & Casualty | Drug Manufacturers - Specialty & Generic | Insurance - Property & Casualty |
| Market Cap | $71M | $509M | $1.98B | $2M | $688M |
| Revenue (TTM) | $0.00 | $335M | $927M | $41M | $776M |
| Net Income (TTM) | $6M | $107M | $303M | $-12M | $202M |
| Gross Margin | — | 63.8% | 66.5% | 30.3% | 35.6% |
| Operating Margin | — | 42.6% | 47.9% | -26.7% | 34.8% |
| Forward P/E | — | 7.5x | 8.9x | — | 4.9x |
| Total Debt | $192K | $152M | $68M | $9M | $100M |
| Cash & Equiv. | $0.00 | $199M | $1.21B | $34M | $559M |
ATII vs ACIC vs HCI vs UPC vs HRTG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Apr 25 | May 26 | Return |
|---|---|---|---|
| Archimedes Tech SPA… (ATII) | 100 | 107.5 | +7.5% |
| American Coastal In… (ACIC) | 100 | 92.1 | -7.9% |
| HCI Group, Inc. (HCI) | 100 | 104.1 | +4.1% |
| Universe Pharmaceut… (UPC) | 100 | 58.6 | -41.4% |
| Heritage Insurance … (HRTG) | 100 | 118.6 | +18.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ATII vs ACIC vs HCI vs UPC vs HRTG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ATII is the #2 pick in this set and the best alternative if stability and momentum is your priority.
- Beta 0.05 vs UPC's 1.11
- +7.4% vs UPC's -41.4%
ACIC is the clearest fit if your priority is defensive.
- Beta 0.24, current ratio 1.22x
HCI carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 2 yrs, beta 0.38, yield 1.0%
- Rev growth 20.2%, EPS growth 179.8%, 3Y rev CAGR 22.3%
- 434.8% 10Y total return vs HRTG's 77.6%
- Lower volatility, beta 0.38, Low D/E 6.1%, current ratio 1.24x
Among these 5 stocks, UPC doesn't own a clear edge in any measured category.
HRTG ranks third and is worth considering specifically for valuation efficiency.
- PEG 0.06 vs HCI's 0.19
- Better valuation composite
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 20.2% revenue growth vs UPC's -22.4% | |
| Value | Better valuation composite | |
| Quality / Margins | 32.6% margin vs UPC's -30.3% | |
| Stability / Safety | Beta 0.05 vs UPC's 1.11 | |
| Dividends | 1.0% yield; 2-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +7.4% vs UPC's -41.4% | |
| Efficiency (ROA) | 12.7% ROA vs UPC's -18.6%, ROIC 6.8% vs -7.8% |
ATII vs ACIC vs HCI vs UPC vs HRTG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
ATII vs ACIC vs HCI vs UPC vs HRTG — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HCI leads in 2 of 6 categories
HRTG leads 2 • ATII leads 1 • ACIC leads 0 • UPC leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
HCI leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HCI and ATII operate at a comparable scale, with $927M and $0 in trailing revenue. HCI is the more profitable business, keeping 32.6% of every revenue dollar as net income compared to UPC's -30.3%. On growth, HCI holds the edge at +11.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $0 | $335M | $927M | $41M | $776M |
| EBITDAEarnings before interest/tax | $2M | $154M | $454M | -$10M | $280M |
| Net IncomeAfter-tax profit | $6M | $107M | $303M | -$12M | $202M |
| Free Cash FlowCash after capex | -$693,975 | $71M | $282M | -$15M | $203M |
| Gross MarginGross profit ÷ Revenue | — | +63.8% | +66.5% | +30.3% | +35.6% |
| Operating MarginEBIT ÷ Revenue | — | +42.6% | +47.9% | -26.7% | +34.8% |
| Net MarginNet income ÷ Revenue | — | +31.9% | +32.6% | -30.3% | +26.0% |
| FCF MarginFCF ÷ Revenue | — | +21.1% | +30.4% | -37.2% | +26.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +9.3% | +11.9% | -14.1% | +0.5% |
| EPS Growth (YoY)Latest quarter vs prior year | — | +4.3% | +23.4% | -100.1% | +20.2% |
Valuation Metrics
HRTG leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 3.5x trailing earnings, HRTG trades at a 42% valuation discount to HCI's 6.1x P/E. Adjusting for growth (PEG ratio), HRTG offers better value at 0.04x vs HCI's 0.13x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $71M | $509M | $2.0B | $2M | $688M |
| Enterprise ValueMkt cap + debt − cash | $71M | $463M | $836M | -$23M | $229M |
| Trailing P/EPrice ÷ TTM EPS | -540.00x | 4.90x | 6.12x | -0.00x | 3.55x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 7.49x | 8.94x | — | 4.85x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.13x | — | 0.04x |
| EV / EBITDAEnterprise value multiple | — | 2.83x | 1.90x | — | 0.84x |
| Price / SalesMarket cap ÷ Revenue | — | 1.52x | 2.20x | 0.09x | 0.81x |
| Price / BookPrice ÷ Book value/share | — | 1.65x | 1.76x | 0.00x | 1.37x |
| Price / FCFMarket cap ÷ FCF | — | 7.18x | 4.45x | — | 3.95x |
Profitability & Efficiency
HCI leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
HRTG delivers a 43.7% return on equity — every $100 of shareholder capital generates $44 in annual profit, vs $-27 for UPC. HCI carries lower financial leverage with a 0.06x debt-to-equity ratio, signaling a more conservative balance sheet compared to ACIC's 0.48x. On the Piotroski fundamental quality scale (0–9), HCI scores 8/9 vs ATII's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | — | +35.7% | +30.8% | -27.0% | +43.7% |
| ROA (TTM)Return on assets | +2.5% | +9.0% | +12.7% | -18.6% | +8.8% |
| ROICReturn on invested capital | — | +41.0% | +6.8% | -7.8% | +15.4% |
| ROCEReturn on capital employed | — | +26.0% | +40.6% | -5.6% | +38.8% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 6 | 8 | 4 | 7 |
| Debt / EquityFinancial leverage | — | 0.48x | 0.06x | 0.16x | 0.20x |
| Net DebtTotal debt minus cash | $192,033 | -$46M | -$1.1B | -$24M | -$459M |
| Cash & Equiv.Liquid assets | $0 | $199M | $1.2B | $34M | $559M |
| Total DebtShort + long-term debt | $192,033 | $152M | $68M | $9M | $100M |
| Interest CoverageEBIT ÷ Interest expense | — | 14.20x | 67.37x | -22.11x | 31.04x |
Total Returns (Dividends Reinvested)
HRTG leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HRTG five years ago would be worth $24,956 today (with dividends reinvested), compared to $3 for UPC. Over the past 12 months, ATII leads with a +7.4% total return vs UPC's -41.4%. The 3-year compound annual growth rate (CAGR) favors HRTG at 76.3% vs UPC's -89.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +4.3% | -0.9% | -17.0% | -32.7% | -17.9% |
| 1-Year ReturnPast 12 months | +7.4% | -5.4% | -0.7% | -41.4% | -12.7% |
| 3-Year ReturnCumulative with dividends | +8.3% | +152.2% | +208.3% | -99.9% | +447.9% |
| 5-Year ReturnCumulative with dividends | +8.3% | +99.0% | +114.1% | -100.0% | +149.6% |
| 10-Year ReturnCumulative with dividends | +8.3% | -24.0% | +434.8% | -100.0% | +77.6% |
| CAGR (3Y)Annualised 3-year return | +2.7% | +36.1% | +45.6% | -89.5% | +76.3% |
Risk & Volatility
ATII leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
ATII is the less volatile stock with a 0.05 beta — it tends to amplify market swings less than UPC's 1.11 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ATII currently trades 99.2% from its 52-week high vs UPC's 25.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.05x | 0.24x | 0.38x | 1.11x | 0.33x |
| 52-Week HighHighest price in past year | $10.89 | $13.06 | $210.50 | $11.00 | $31.98 |
| 52-Week LowLowest price in past year | $10.05 | $9.79 | $136.37 | $2.00 | $16.83 |
| % of 52W HighCurrent price vs 52-week peak | +99.2% | +80.6% | +72.3% | +25.5% | +70.1% |
| RSI (14)Momentum oscillator 0–100 | 68.4 | 39.1 | 46.6 | 47.8 | 50.3 |
| Avg Volume (50D)Average daily shares traded | 178K | 185K | 167K | 8K | 309K |
Analyst Outlook
Evenly matched — HCI and UPC each lead in 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: ACIC as "Hold", HCI as "Buy", HRTG as "Buy". Consensus price targets imply 74.0% upside for HRTG (target: $39) vs -82.0% for ACIC (target: $2). HCI is the only dividend payer here at 0.98% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Buy | — | Buy |
| Price TargetConsensus 12-month target | — | $1.90 | $126.50 | — | $39.00 |
| # AnalystsCovering analysts | — | 5 | 14 | — | 9 |
| Dividend YieldAnnual dividend ÷ price | — | — | +1.0% | — | — |
| Dividend StreakConsecutive years of raises | — | 1 | 2 | 2 | 1 |
| Dividend / ShareAnnual DPS | — | — | $1.50 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +0.1% | 0.0% | +0.3% |
HCI leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). HRTG leads in 2 (Valuation Metrics, Total Returns). 1 tied.
ATII vs ACIC vs HCI vs UPC vs HRTG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ATII or ACIC or HCI or UPC or HRTG a better buy right now?
For growth investors, HCI Group, Inc.
(HCI) is the stronger pick with 20. 2% revenue growth year-over-year, versus -22. 4% for Universe Pharmaceuticals Inc. (UPC). Heritage Insurance Holdings, Inc. (HRTG) offers the better valuation at 3. 5x trailing P/E (4. 9x forward), making it the more compelling value choice. Analysts rate HCI Group, Inc. (HCI) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ATII or ACIC or HCI or UPC or HRTG?
On trailing P/E, Heritage Insurance Holdings, Inc.
(HRTG) is the cheapest at 3. 5x versus HCI Group, Inc. at 6. 1x. On forward P/E, Heritage Insurance Holdings, Inc. is actually cheaper at 4. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Heritage Insurance Holdings, Inc. wins at 0. 06x versus HCI Group, Inc. 's 0. 19x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — ATII or ACIC or HCI or UPC or HRTG?
Over the past 5 years, Heritage Insurance Holdings, Inc.
(HRTG) delivered a total return of +149. 6%, compared to -100. 0% for Universe Pharmaceuticals Inc. (UPC). Over 10 years, the gap is even starker: HCI returned +434. 8% versus UPC's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ATII or ACIC or HCI or UPC or HRTG?
By beta (market sensitivity over 5 years), Archimedes Tech SPAC Partners II Co.
Ordinary Shares (ATII) is the lower-risk stock at 0. 05β versus Universe Pharmaceuticals Inc. 's 1. 11β — meaning UPC is approximately 1986% more volatile than ATII relative to the S&P 500. On balance sheet safety, HCI Group, Inc. (HCI) carries a lower debt/equity ratio of 6% versus 48% for American Coastal Insurance Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — ATII or ACIC or HCI or UPC or HRTG?
By revenue growth (latest reported year), HCI Group, Inc.
(HCI) is pulling ahead at 20. 2% versus -22. 4% for Universe Pharmaceuticals Inc. (UPC). On earnings-per-share growth, the picture is similar: Heritage Insurance Holdings, Inc. grew EPS 214. 4% year-over-year, compared to 26. 5% for Universe Pharmaceuticals Inc.. Over a 3-year CAGR, HCI leads at 22. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ATII or ACIC or HCI or UPC or HRTG?
HCI Group, Inc.
(HCI) is the more profitable company, earning 33. 2% net margin versus -20. 6% for Universe Pharmaceuticals Inc. — meaning it keeps 33. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HCI leads at 47. 7% versus -16. 3% for UPC. At the gross margin level — before operating expenses — ACIC leads at 86. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ATII or ACIC or HCI or UPC or HRTG more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Heritage Insurance Holdings, Inc. (HRTG) is the more undervalued stock at a PEG of 0. 06x versus HCI Group, Inc. 's 0. 19x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Heritage Insurance Holdings, Inc. (HRTG) trades at 4. 9x forward P/E versus 8. 9x for HCI Group, Inc. — 4. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HRTG: 74. 0% to $39. 00.
08Which pays a better dividend — ATII or ACIC or HCI or UPC or HRTG?
In this comparison, HCI (1.
0% yield) pays a dividend. ATII, ACIC, UPC, HRTG do not pay a meaningful dividend and should not be held primarily for income.
09Is ATII or ACIC or HCI or UPC or HRTG better for a retirement portfolio?
For long-horizon retirement investors, HCI Group, Inc.
(HCI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 38), 1. 0% yield, +434. 8% 10Y return). Both have compounded well over 10 years (HCI: +434. 8%, UPC: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ATII and ACIC and HCI and UPC and HRTG?
These companies operate in different sectors (ATII (Financial Services) and ACIC (Financial Services) and HCI (Financial Services) and UPC (Healthcare) and HRTG (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ATII is a small-cap quality compounder stock; ACIC is a small-cap deep-value stock; HCI is a small-cap high-growth stock; UPC is a small-cap quality compounder stock; HRTG is a small-cap deep-value stock. HCI pays a dividend while ATII, ACIC, UPC, HRTG do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.